ImmunityBio, Inc. , a leading immunotherapy company, today announced significant progress in its ongoing discussions with the U.S. Food and Drug Administration (FDA) regarding three areas of its ...

Idorsia will conduct a proof-of-concept study for patients with vitiligo. Unique precision medicine with a dual targeting of ...

Panelists discuss how the decision to treat vs observe alopecia areata (AA) depends on factors such as disease severity, ...

The following is a summary of “Monocytic reactive oxygen species-induced T cell apoptosis impairs cellular immune response to ...

2025年1月13日，清华大学生命学院江鹏课题组与武汉科技大学祝海川课题组、北京大学张泽民课题组和李程组合作，在Nature Cancer期刊以长文的形式发表了题为“ETV7 limits the antiviral and anti-tumor ...

Occupational pesticide exposure threatens women's health as it leads to an increase in breast cancer risk for young women, ...

Choi Hyung-jin wins Im Seong-ki Researcher Award for obesity treatment breakthroughs Choi Hyung-jins groundbreaking ...

Presented updated clinical and biomarker activity data at the IOVC in October 2024. Investigators reported ongoing improved ...

The following is a summary of “FC03 T17 polarization of skin-homing (CLA-positive) T cells is maintained by ...

Hookipa Pharma (HOOK – Research Report) received a Hold rating and price target from Citi analyst Sean Lee on January 10. The company’s ...

Cancer researchers at the University of Leicester have developed a technique that could predict how well some breast cancer ...